Biotech

Agilent Investing $725 Million to Expand State-of-the-Art Manufacturing Capacity for Production of Nucleic Acid-Based Therapeutics

Agilent Technologies Inc. (NYSE: A)  announced it is investing approximately $725 million to double manufacturing capacity of therapeutic nuclei...

 January 13, 2023 | News

Emerson Collaborates with Atos to Accelerate Digitalization in life sciences

Global software and engineering leader Emerson has signed a collaborative agreement with Atos, a global leader in digital transformation, to provide softwa...

 January 13, 2023 | News

Thermo Fisher Scientific Joins Momentum Labs as Founding Sponsor of New Biotech Hub in Alachua, Florida

 As part of its efforts to support emerging biotechnology companies with addressing key challenges of bringing new therapies to market, Thermo Fisher ...

 January 12, 2023 | News

Juniper Biologics Partners With Caris Life Sciences® for Molecular Profiling Distribution in South East Asia

The company's suite of market-leading molecular profiling offerings assess DNA, RNA and proteins to reveal a molecular blueprint that helps patients, physi...

 January 12, 2023 | News

Novogene Announces Deployment of Illumina NovaSeq™ X Plus and PacBio REVIO Sequencing Systems

Novogene is a trusted genomics partner to scientists worldwide and provides access to the latest genomics tools to the scientific community. The acquisitio...

 January 06, 2023 | News

Thermo Fisher Scientific Completes Acquisition of The Binding Site Group

Expands Specialty Diagnostics Segment with Industry Leader in Oncology Testing for Detection and Monitoring of Multiple Myeloma  Complements Existing...

 January 03, 2023 | News

Legend Biotech Announces Acceptance of Its New Drug Application for Ciltacabtagene Autoleucel (Cilta-Cel) in China

This submission is based on data from the confirmatory Phase 2 clinical study CARTIFAN-1 (NCT03758417) conducted in China, which evaluated the efficacy and...

 January 03, 2023 | News

Merck Announces Collaboration With Mersana Therapeutics to Develop Novel Immunostimulatory Antibody-Drug Conjugates

Collaboration complements Merck’s internal expertise and in-house ADC approach Companies focused on discovering novel STING-agonist ADCs for up to...

 December 23, 2022 | News

Novavax Announces Pricing of its $150 Million Convertible Debenture Offering

The Notes are currently being offered and sold only to persons who are reasonably qualified institutional purchasers within the meaning of Rule 144A under ...

 December 19, 2022 | News

Merck Signs MoU with Synplogen to Accelerate Development and Manufacturing of Viral Vector-based Gene Therapy Applications

Merck’s Millipore® CTDMO Services (Contract Testing, Development and Manufacturing Organization) to streamline viral vector development and pro...

 December 14, 2022 | News

Lilly Announces 15% Dividend Increase, First-Quarter 2023 Dividend

The dividend is payable on March 10, 2023 to shareholders of record at the close of business on Feb. 15, 2023.   Lilly unites caring with ...

 December 13, 2022 | News

Merck Gains Leading Perfusion Micro-Bioreactor with Erbi Biosystems Acquisition

Erbi’s differentiated 2 ml micro-bioreactor platform technology, Breez™, enables rapid lab testing for bioprocessing scale up Allows Merck t...

 December 07, 2022 | News

JelloX Biotech Leads Research in 3D Cancer Pathology as NCI Explores Potential

Presently, most cancer diagnosis is done through thinly sliced physical biopsies. Though widespread, the amount of information this method collects remains...

 December 06, 2022 | News

GE Healthcare Highlights Transformative Precision Innovations and Collaborations that Help Drive the Future of Health

Drawing on more than 100 years of history as a trusted medical technology innovator1, GE Healthcare is closely connected with healthcare systems globally. ...

 November 28, 2022 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close